Vulvar cancer natural history: Difference between revisions
| Line 22: | Line 22: | ||
|style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Stage'''|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | '''5-year relative survival (%)''' | |style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Stage'''|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | '''5-year relative survival (%)''' | ||
|- | |- | ||
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align= | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=center |'''I'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=center|93% | ||
|- | |- | ||
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align= | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=center |'''II'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=center |79% | ||
|- | |- | ||
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align= | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=center |'''III'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=center | 53% | ||
|- | |- | ||
| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align= | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=center |'''1V'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=center |29% | ||
|} | |} | ||
Revision as of 13:59, 7 October 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
|
Vulvar cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vulvar cancer natural history On the Web |
|
American Roentgen Ray Society Images of Vulvar cancer natural history |
|
Risk calculators and risk factors for Vulvar cancer natural history |
Overview
If left untreated, patients with vulvar cancer may progress to develop ulcer on vulva or wart-like patches on vulva, chronic pruritus of the vulva and lichenification. Common complications of vulvar cancer include fistula and metastasis. Prognosis is generally good, and the 5 year survival rate of patients with vulvar cancer is approximately 71.2%.[1]
Natural history
- In younger age group, HPV infection can be the cause of vulvar cancer. Vulvar cancer may be associated vulvar dermatoses, such as lichen sclerosus, especially in older age group.
- Patient has early symptoms like ulcer on vulva, chronic pruritus of the vulva, lichenification, and wart-like patches on vulva.
- As the tumor grows larger, patient may notice symptoms like unusual bleeding or discharge from the lesion, large mass on the vulva, dysuria and dyspareunia.
- In advanced disease, metastases may be present in the abdomen, lungs.
- The patient may present with dyspnea, cough with blood-stained sputum, persistent pain or discomfort in the chest, edema hands/feet, and inguinal lymphadenopathy.
- Once the cancer spreads to the other organs, it is most likely fatal.
Complications
- Pelvic pain
- Fistula
- Metastasis - usually in the liver and lungs but may occur in other sites
Prognosis
Vulvar cancer is associated with a 5 year survival rate of 71.2%. Following is the table for squamous cell carcinoma of the vulva survival.[1]
| Stage | 5-year relative survival (%) |
| I | 93% |
| II | 79% |
| III | 53% |
| 1V | 29% |
References
- ↑ 1.0 1.1 Survival statistics for vulvar cancer. Vulvar cancer. http://www.cancer.ca/en/cancer-information/cancer-type/vulvar/prognosis-and-survival/survival-statistics/?region=ns Accessed on October 1, 2015